Investing

The 52-Week Low Club for Tuesday

March 22, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Tuesday’s session.

AstraZeneca PLC (NYSE: AZN) dropped about 2.5% on Tuesday to post a new 52-week low at $27.68 after closing at $28.40 on Monday. The stock’s 52-week high is $36.69. Share volume of about 6.3 million was 30% higher than the daily average of around 4.8 million shares traded. The company’s stock was downgraded from Buy to Hold this morning at Jefferies.

Pepco Holdings Inc. (NYSE: POM) fell by about 3.3% on Tuesday to post a new 52-week low of $21.25 against a high of $27.34. The stock closed at $21.97 on Monday night. Volume rose to around 6.3 million shares, about 40% higher than the daily average of around 3.6 million shares traded. The utility company had no news on Tuesday.

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) posted a new 52-week low on Tuesday. Shares traded at a low of $2.60, down about 6.8%, after closing at $2.79 on Monday. The stock’s 52-week high is $10.15. Volume approached double the daily average of around 2.3 million shares. The company also had no specific news Tuesday.

Vivint Solar Inc. (NYSE: VSLR) dropped about 3% on Tuesday to post a new 52-week low of $3.26 against a 52-week high of $16.00. The stock closed at $3.36 on Monday night. Volume totaled about 2.7 million shares compared with the stock’s daily average volume of around 644,000. The solar installer announced this morning that it had closed a $200 million term credit facility.

Find a Qualified Financial Advisor (Sponsor)

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.